Johnson & Johnson ordered to pay $417 million in trial over talc cancer risks

Johnson & Johnson on Monday was ordered by a California jury to pay $417 million to a woman who claimed she developed ovarian cancer after using the company`s talc-based products like Johnson`s Baby Powder for feminine hygiene.

The Los Angeles Superior Court jury`s verdict in favor of California resident Eva Echeverria was the largest to date in lawsuits alleging J&J failed to adequately warn consumers about the cancer risks of talc-based products.

The verdict was confirmed by a spokeswoman for Echeverria`s lawyers. J&J said it will appeal.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)